EUROPEAN, COMMISSION

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS

Veröffentlicht: 17.03.2026 um 17:53 Uhr, prnewswire.co.uk

Amgen California

View original content:https://www.prnewswire.co.uk/news-releases/european-commission-approves-amgens-uplizna-for-generalized-myasthenia-gravis-302686432.html

en | boerse | 68717540 |